We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$335B
AUM Growth
+$21B
Cap. Flow
-$4B
Cap. Flow %
-1.19%
Top 10 Hldgs %
21.52%
Holding
3,670
New
323
Increased
1,420
Reduced
1,524
Closed
323

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.66B
2
BABA icon
Alibaba
BABA
+$881M
3
INTC icon
Intel
INTC
+$783M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$783M
5
LIN icon
Linde
LIN
+$667M

Sector Composition

Rank Sector Weight
1 Technology 23.8%
2 Financials 13%
3 Consumer Discretionary 12.7%
4 Healthcare 12.61%
5 Communication Services 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICAD
2876
DELISTED
iCAD Inc
ICAD
$1.31M ﹤0.01%
75,707
+8,711
+13% +$153K
ALGS icon
2877
Aligos Therapeutics
ALGS
$34.9M
$1.31M ﹤0.01%
2,569
+1,595
+164% +$1.02M
SRRK icon
2878
Scholar Rock
SRRK
$6.44B
$1.31M ﹤0.01%
95,257
-19,706
-17% -$603K
NGNE icon
2879
Neurogene
NGNE
$712M
$1.3M ﹤0.01%
7,038
-56
-0.8% -$12.4K
CIVB icon
2880
Civista Bancshares
CIVB
$589M
$1.3M ﹤0.01%
58,746
-27,271
-32% -$630K
EBTC
2881
DELISTED
Enterprise Bancorp
EBTC
$1.3M ﹤0.01%
39,638
-367
-0.9% -$12.5K
FNLC icon
2882
First Bancorp
FNLC
$399M
$1.3M ﹤0.01%
44,035
-6,784
-13% -$203K
ITI
2883
DELISTED
Iteris, Inc.
ITI
$1.3M ﹤0.01%
194,877
-35,503
-15% -$239K
CRDF icon
2884
Cardiff Oncology
CRDF
$77.2M
$1.29M ﹤0.01%
+194,241
New +$1.65M
GNTY
2885
DELISTED
Guaranty Bancshares
GNTY
$1.29M ﹤0.01%
37,820
+3,863
+11% +$147K
ITUB icon
2886
Itaú Unibanco
ITUB
$87.5B
$1.29M ﹤0.01%
294,139
+236,254
+408% +$952K
CVLG icon
2887
Covenant Logistics
CVLG
$872M
$1.29M ﹤0.01%
124,370
-11,674
-9% -$126K
PTGX icon
2888
Protagonist Therapeutics
PTGX
$9.44B
$1.29M ﹤0.01%
166,325
+21,625
+15% +$714K
GLRE icon
2889
Greenlight Captial
GLRE
$506M
$1.28M ﹤0.01%
140,476
-12,966
-8% -$119K
LCTX icon
2890
Lineage Cell Therapeutics
LCTX
$278M
$1.28M ﹤0.01%
+449,911
New +$1.16M
SYRE icon
2891
Spyre Therapeutics
SYRE
$9.25B
$1.28M ﹤0.01%
7,371
+1,056
+17% +$192K
QTNT
2892
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1.28M ﹤0.01%
8,780
+1,468
+20% +$235K
MAGN
2893
Magnera Corp
MAGN
$460M
$1.28M ﹤0.01%
15,571
-8,693
-36% -$1.71M
GTBP icon
2894
GT Biopharma
GTBP
$11.5M
$1.27M ﹤0.01%
+2,738
New +$1.14M
CNTY icon
2895
Century Casinos
CNTY
$34M
$1.27M ﹤0.01%
94,756
-29,599
-24% -$386K
CURI icon
2896
CuriosityStream
CURI
$161M
$1.27M ﹤0.01%
+93,130
New +$1.2M
HYRE
2897
DELISTED
HyreCar Inc. Common Stock
HYRE
$1.26M ﹤0.01%
+60,381
New +$928K
IVC
2898
DELISTED
Invacare Corporation
IVC
$1.26M ﹤0.01%
156,343
-8,707
-5% -$72.5K
SGC icon
2899
Superior Group of Companies
SGC
$225M
$1.26M ﹤0.01%
52,743
-607
-1% -$15.3K
RPT
2900
Rithm Property Trust
RPT
$93.7M
$1.25M ﹤0.01%
16,009
-418
-3% -$30.8K

Similar funds

Nuveen's Q2 2021 Portfolio in Review

As of Q2 2021, Nuveen held 3,670 positions worth $335B, up 6.7% from $314B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q2 2021 filing shows 323 new, 1,420 increased, 1,524 reduced and 323 closed positions. Its largest new stake was UiPath: 2,457,331 shares worth $167M. The largest sale was Apple, an estimated $1.66B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Nuveen's largest Q2 2021 buy was UiPath: 2,457,331 shares worth $167M.
  • Nuveen added most to Wells Fargo in Q2 2021, an estimated $512M increase.
  • Nuveen's biggest Q2 2021 reduction was Apple, cutting an estimated $1.66B.
  • Nuveen fully exited SolarEdge in Q2 2021, selling an estimated $66M.
  • Nuveen's ten largest holdings make up 22% of its $335B portfolio in Q2 2021.
  • Nuveen opened 323 new positions and closed 323 in Q2 2021.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $335B.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.